CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/02/2023
Voltar para busca
Dado oficial do USPTO
NEOGENOMICS EUROPE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NEOGENOMICS EUROPE
ST13
US500000087580599Classe
42, 44
Pedido
87580599
Registro
6471194
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
80
Atualização mais recente
01/02/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
23/08/2017
Data de registro
31/08/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/08/2021
Última transação
13/06/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2017-11-00
Primeiro uso no comércio
2017-11-00
Código do desenho
4
Tipo de titular
03
Localização do titular
Fort Myers, FL, US
Examinador
DUBOIS, SUSAN
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc.
Representantes
Anessa O. Kramer Honigman LLP
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Genetic mapping for scientific purposes; gene sequencing; molecular sequencing; cancer study and analysis; clinical study and testing of cells; medical and scientific research information in the field of gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cells; scientific research in the field of gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cellscancer; providing information to others in the fields of oncologypathology and gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research servicesmedical research servicesclinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research servicesmedical research servicesclinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; temporary use of online non-downloadable software for enhancement of analysisresearchreview of information pertaining to medicalscientificgenetictesting and analysisinformation and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; non-downloadable computer software for enhancement of analysisresearchreview of information pertaining to medicalscientificgenetictesting and analysisinformation pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology ; genetic testingrna testing and sequencing; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory servicesoncology reference laboratory servicesproviding informationinteractive informationreportsto others in the field of pathologydiagnostic testingoncology testing; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; medical and scientific researchconducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals
Classe 44
Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human diseasehuman medical conditionsmedical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human diseasehuman medical conditionsmedical diagnostic testing servicesmedical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human diseasehuman medical conditionsmedical diagnostic testing servicesmedical testing for diagnostic or treatment purposes; medical testing for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; Medical diagnostic testing to aid in diagnosisprognosis and therapy selection; oncology reference laboratory services
Publicações
Histórico de despachos e eventos da marca no USPTO.
80 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
31/08/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
29/07/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
28/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/07/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/07/2021
GNRT
NON-FINAL ACTION E-MAILED
19/07/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
19/07/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/07/2021
IUAF
USE AMENDMENT FILED
01/07/2021
EISU
TEAS STATEMENT OF USE RECEIVED
01/07/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/12/2020
EX5G
SOU EXTENSION 5 GRANTED
17/12/2020
EXT5
SOU EXTENSION 5 FILED
14/12/2020
EEXT
SOU TEAS EXTENSION RECEIVED
14/12/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/12/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/12/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/12/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/12/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/12/2020
DOCK
ASSIGNED TO EXAMINER
23/07/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/07/2020
EX4G
SOU EXTENSION 4 GRANTED
06/07/2020
EXT4
SOU EXTENSION 4 FILED
01/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/07/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/07/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/07/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/07/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/07/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/07/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21/12/2019
EX3G
SOU EXTENSION 3 GRANTED
20/12/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/12/2019
EXT3
SOU EXTENSION 3 FILED
16/12/2019
EEXT
SOU TEAS EXTENSION RECEIVED
16/12/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/07/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27/06/2019
EX2G
SOU EXTENSION 2 GRANTED
25/06/2019
EXT2
SOU EXTENSION 2 FILED
25/06/2019
EEXT
SOU TEAS EXTENSION RECEIVED
25/06/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/12/2018
EX1G
SOU EXTENSION 1 GRANTED
21/12/2018
EXT1
SOU EXTENSION 1 FILED
21/12/2018
EEXT
SOU TEAS EXTENSION RECEIVED
21/12/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/07/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/05/2018
PUBO
PUBLISHED FOR OPPOSITION
08/05/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/04/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/03/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/12/2017
GNRT
NON-FINAL ACTION E-MAILED
01/12/2017
CNRT
NON-FINAL ACTION WRITTEN
01/12/2017
DOCK
ASSIGNED TO EXAMINER
29/11/2017
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/09/2017
ALIE
ASSIGNED TO LIE
10/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/08/2017
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
28/08/2017
NWAP
NEW APPLICATION ENTERED
26/08/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEOGENOMICS EUROPE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.